Ascelis Center of Excellence for Peptide Development and Characterization will drive the development of cosmetic, therapeutic, and pharmaceutical peptides
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US
The proposed transaction will be effected as a share swap
Gobivaz is authorised for adults with rheumatoid arthritis (in combination with methotrexate), psoriatic arthritis (with or without methotrexate), axial spondyloarthritis, and ulcerative colitis
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
Total income for the period stood at Rs. 7101.28 crore
Diversifying its portfolio to include late-phase antiviral agent
Subscribe To Our Newsletter & Stay Updated
